Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
MESO
MESO
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
MESO News
Mesoblast Acquires Exclusive CAR Technology License
5d ago
seekingalpha
Mesoblast Acquires CAR Technology Platform for MSC Products
5d ago
NASDAQ.COM
Mesoblast Secures Exclusive Global License for CAR Technology
5d ago
NASDAQ.COM
Mesoblast Secures Exclusive Global License for CAR Technology
6d ago
Newsfilter
Mesoblast Receives FDA Approval for DMD Clinical Trial
Apr 10 2026
Newsfilter
Mesoblast Unveils Strategy to Double Revenues as Ryoncil Approaches $100M Milestone
Apr 08 2026
Newsfilter
Mesoblast Receives FDA Approval for DMD Study of Ryoncil
Apr 08 2026
seekingalpha
Mesoblast Receives FDA Clearance for DMD Clinical Trial
Apr 08 2026
NASDAQ.COM
Mesoblast Receives FDA Approval for DMD Clinical Trial
Apr 08 2026
Newsfilter
MESOBLAST GETS FDA IND APPROVAL TO INITIATE REGISTRATIONAL TRIAL FOR RYONCIL
Apr 08 2026
moomoo
MESOBLAST LTD - FDA Approves RYONCIL IND for DMD Registration Trial
Apr 08 2026
moomoo
Mesoblast Reports Ryoncil Sales Data for Q2 2026
Apr 07 2026
seekingalpha
Mesoblast Reports Strong Ryoncil® Sales Growth
Apr 07 2026
Newsfilter
MESOBLAST LTD - RYONCIL QUARTERLY NET REVENUE RISES TO US$30.3M
Apr 07 2026
moomoo
Avaí Bio Initiates Production of α-Klotho Cell Bank
Mar 18 2026
Globenewswire
Avaí Bio Initiates Production of α-Klotho Cells
Mar 18 2026
PRnewswire
Show More News
